<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">Hyperglycaemia</z:e> in <z:hpo ids='HP_0011009'>acute</z:hpo> ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> is traditionally associated with a worsened outcome </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is unclear whether the impact of <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> on <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome is similar in lacunar and non-<z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarctions</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The relation between serum <z:chebi fb="105" ids="17234">glucose</z:chebi> measured within 6 h after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> and functional outcome was investigated in 1375 ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> patients who had been included in two placebo-controlled trials with lubeluzole </plain></SENT>
<SENT sid="3" pm="."><plain>The endpoint was a favourable outcome, defined as a modified Rankin Scale score &lt; or =2 at 3 months </plain></SENT>
<SENT sid="4" pm="."><plain>Classification into lacunar (n = 168) and non-lacunar (n = 1207) <z:hpo ids='HP_0001297'>strokes</z:hpo> was based on clinical criteria according to the Oxfordshire Community <z:hpo ids='HP_0001297'>Stroke</z:hpo> Project and findings on brain CT scan </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">Hyperglycaemia</z:e> was defined as blood <z:chebi fb="105" ids="17234">glucose</z:chebi> &gt;8 mmol/l </plain></SENT>
<SENT sid="6" pm="."><plain>A possible concentration-dependent effect of <z:chebi fb="105" ids="17234">glucose</z:chebi> on outcome was investigated in both lacunar and non-lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Multivariate analysis showed that <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> was associated with decreased odds of a favourable outcome in non-lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo> (OR 0.60; 95% CI 0.41-0.88, P = 0.009), but with increased odds of a favourable outcome in lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo> (multivariate OR for <z:chebi fb="105" ids="17234">glucose</z:chebi> &gt;8 mmol/l: 2.70; 95% CI 1.01-7.13, P = 0.048) </plain></SENT>
<SENT sid="8" pm="."><plain>In non-lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo>, there appeared to be a concentration-effect relation, as the odds of favourable outcome gradually decreased with increasing <z:chebi fb="105" ids="17234">glucose</z:chebi> levels </plain></SENT>
<SENT sid="9" pm="."><plain>In lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo>, an association with favourable outcome was observed with <z:chebi fb="105" ids="17234">glucose</z:chebi> levels &gt;8 mmol/l, but this beneficial effect diminished with more severe <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> &gt;12 mmol/l </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> has a detrimental effect in non-lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo>, but moderate <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> may be beneficial in lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>